Treatment of Cryptococcal Meningitis
The recommended treatment for cryptococcal meningitis is induction therapy with amphotericin B deoxycholate (0.7-1.0 mg/kg/day) plus flucytosine (100 mg/kg/day) for 2 weeks, followed by fluconazole (400 mg/day) for 8-10 weeks as consolidation therapy, and then fluconazole (200 mg/day) for maintenance. 1
Treatment Regimens Based on Immune Status
HIV-Associated Cryptococcal Meningitis
- Induction: Amphotericin B deoxycholate (0.7-1.0 mg/kg/day IV) plus flucytosine (100 mg/kg/day orally in 4 divided doses) for 2 weeks 2, 1
- Consolidation: Fluconazole 400 mg daily for 8 weeks 2, 1
- Maintenance: Fluconazole 200 mg daily for at least 1 year or until immune reconstitution 1, 3
- Antiretroviral therapy should be initiated 2-10 weeks after starting antifungal treatment to reduce risk of IRIS 1
Non-HIV Immunocompromised Patients
- Induction: Amphotericin B (0.7-1.0 mg/kg/day) plus flucytosine (100 mg/kg/day) for 2 weeks 2
- Consolidation: Fluconazole (400-800 mg/day) for 8-10 weeks 2
- Maintenance: Fluconazole (200 mg/day) for 6-12 months 2
Immunocompetent Patients
- Option 1: Amphotericin B plus flucytosine for 6 weeks (most effective) 2
- Option 2: Amphotericin B (0.5-1 mg/kg/day) plus flucytosine (100 mg/kg/day) for 2 weeks, followed by fluconazole (400 mg/day) for 8-10 weeks 2
Alternative Regimens
- For patients with renal impairment: Liposomal amphotericin B (AmBisome) 4 mg/kg/day can be substituted for conventional amphotericin B 2, 1
- When flucytosine is unavailable: Amphotericin B plus fluconazole (400-800 mg/day) 1
- When amphotericin B cannot be used: Fluconazole (1200 mg daily) plus flucytosine (100 mg/kg/day) for 2 weeks 1
- For patients unable to tolerate fluconazole: Itraconazole (200 mg twice daily) may be substituted 2
Recent Evidence on Treatment Duration
- The most recent evidence supports shorter courses of amphotericin B (1 week) when combined with flucytosine 4
- A 2022 study demonstrated that a single high dose of liposomal amphotericin B (10 mg/kg) plus 14 days of flucytosine and fluconazole was noninferior to the standard 7-day amphotericin B deoxycholate regimen 5
Monitoring and Management
- Lumbar puncture should be performed after 2 weeks of treatment to assess CSF sterilization 2
- Patients with positive CSF cultures at 2 weeks require longer induction therapy 2
- Monitor for increased intracranial pressure and manage aggressively with repeated lumbar punctures 2, 1
- For patients receiving flucytosine, monitor serum levels (target: 30-80 μg/mL) and adjust dose based on renal function 2, 1
- Regular monitoring of renal function, electrolytes, and complete blood counts is essential during amphotericin B therapy 1, 3
Evidence Supporting Combination Therapy
- Combination therapy with amphotericin B plus flucytosine is associated with improved survival compared to amphotericin B alone 4
- The addition of flucytosine to amphotericin B significantly increases the rate of CSF sterilization 4, 6
- A meta-analysis showed a 44% reduction in mortality at 2 weeks with amphotericin B plus flucytosine compared to other regimens 7
Common Pitfalls and Caveats
- Initial therapy with fluconazole alone, even among "low risk" patients, is discouraged due to unsatisfactory outcomes 2
- Treatment decisions should not be based solely on cryptococcal antigen titers in either serum or CSF 2, 1
- Inadequate management of increased intracranial pressure is associated with high mortality 2, 1
- Premature initiation of antiretroviral therapy in HIV patients can lead to immune reconstitution inflammatory syndrome (IRIS) 1
- Failure to monitor for drug toxicities, especially with amphotericin B and flucytosine, can lead to serious adverse events 1
Dosing in Special Populations
- For children: Amphotericin B plus flucytosine for induction, followed by fluconazole (12 mg/kg on first day, then 6 mg/kg daily) 8
- For patients with renal impairment: Dose adjustment is required for fluconazole based on creatinine clearance 8
- For patients on hemodialysis: 100% of the recommended fluconazole dose should be given after each hemodialysis 8